Gyroscope Therapeutics Hldgs Ltd (VISN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,460 | 0 | 0 | 0 | -24,050 |
| Depreciation Amortization | 3,340 | 0 | 0 | 0 | 4,160 |
| Income taxes - deferred | 152 | 0 | 0 | 0 | 303 |
| Accounts receivable | -5,342 | 0 | 0 | 0 | -1,296 |
| Accounts payable and accrued liabilities | 1,251 | 0 | 0 | 0 | -2,136 |
| Other Working Capital | 14,440 | 0 | 0 | 0 | 7,570 |
| Other Operating Activity | 11,289 | 0 | 0 | 0 | 6,459 |
| Operating Cash Flow | $-6,330 | $0 | $0 | $0 | $-8,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,190 | 0 | 0 | 0 | -1,450 |
| Purchase Of Investment | 0 | 0 | 0 | 0 | -160 |
| Purchase Sale Intangibles | -2 | 0 | 0 | 0 | -92 |
| Other Investing Activity | 360 | 0 | 0 | 0 | 2,400 |
| Investing Cash Flow | $-1,830 | $0 | $0 | $0 | $790 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,629 | 0 | 0 | 0 | 24,548 |
| Debt Repayment | -14,002 | 0 | 0 | 0 | -7,487 |
| Other Financing Activity | 1,643 | 0 | 0 | 0 | -1 |
| Financing Cash Flow | $-10,730 | $0 | $0 | $0 | $17,060 |
| Exchange Rate Effect | -560 | 0 | 0 | 0 | 1,080 |
| Beginning Cash Position | 38,940 | 0 | 0 | 0 | 29,010 |
| End Cash Position | 19,480 | 0 | 0 | 0 | 38,940 |
| Net Cash Flow | $-19,460 | $0 | $0 | $0 | $9,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,330 | 0 | 0 | 0 | -8,990 |
| Capital Expenditure | -2,196 | 0 | 0 | 0 | -1,534 |
| Free Cash Flow | -8,526 | 0 | 0 | 0 | -10,524 |